相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Anti-Fas/CD95 and tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) differentially regulate apoptosis in normal and neoplastic human basophils
Anja Foerster et al.
LEUKEMIA & LYMPHOMA (2013)
Chimeric Antigen Receptor-Modified T Cells for Acute Lymphoid Leukemia
Stephan A. Grupp et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
CD19-Targeted T Cells Rapidly Induce Molecular Remissions in Adults with Chemotherapy-Refractory Acute Lymphoblastic Leukemia
Renier J. Brentjens et al.
SCIENCE TRANSLATIONAL MEDICINE (2013)
The Third Signal Cytokine IL-12 Rescues the Anti-Viral Function of Exhausted HBV-Specific CD8 T Cells
Anna Schurich et al.
PLOS PATHOGENS (2013)
Generation of CD19-chimeric antigen receptor modified CD8+ T cells derived from virus-specific central memory T cells
Seitaro Terakura et al.
BLOOD (2012)
Tumor-targeted T cells modified to secrete IL-12 eradicate systemic tumors without need for prior conditioning
Hollie J. Pegram et al.
BLOOD (2012)
Long-term proliferation of functional human NK cells, with conversion of CD56dim NK cells to a CD56bright phenotype, induced by carcinoma cells co-expressing 4-1BBL and IL-12
Alexander C. Dowell et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2012)
Local Delivery of Interleukin-12 Using T Cells Targeting VEGF Receptor-2 Eradicates Multiple Vascularized Tumors in Mice
Dhanalakshmi Chinnasamy et al.
CLINICAL CANCER RESEARCH (2012)
Nitric oxide short-circuits interleukin-12-mediated tumor regression
Nejat K. Egilmez et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2011)
IL-12 Release by Engineered T Cells Expressing Chimeric Antigen Receptors Can Effectively Muster an Antigen-Independent Macrophage Response on Tumor Cells That Have Shut Down Tumor Antigen Expression
Markus Chmielewski et al.
CANCER RESEARCH (2011)
Durable Complete Responses in Heavily Pretreated Patients with Metastatic Melanoma Using T-Cell Transfer Immunotherapy
Steven A. Rosenberg et al.
CLINICAL CANCER RESEARCH (2011)
Costimulation by chimeric antigen receptors revisited: the T cell antitumor response benefits from combined CD28-OX40 signalling
Andreas A. Hombach et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
Tumor-infiltrating myeloid cells induce tumor cell resistance to cytotoxic T cells in mice
Tangying Lu et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
IL-12 triggers a programmatic change in dysfunctional myeloid-derived cells within mouse tumors
Sid P. Kerkar et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Improving Adoptive T Cell Therapy by Targeting and Controlling IL-12 Expression to the Tumor Environment
Ling Zhang et al.
MOLECULAR THERAPY (2011)
T Cells with Chimeric Antigen Receptors Have Potent Antitumor Effects and Can Establish Memory in Patients with Advanced Leukemia
Michael Kalos et al.
SCIENCE TRANSLATIONAL MEDICINE (2011)
Tumor-Specific CD8+ T Cells Expressing Interleukin-12 Eradicate Established Cancers in Lymphodepleted Hosts
Sid P. Kerkar et al.
CANCER RESEARCH (2010)
Building Better Chimeric Antigen Receptors for Adoptive T Cell Therapy
John S. Bridgeman et al.
CURRENT GENE THERAPY (2010)
Engineering CD19-specific T lymphocytes with interleukin-15 and a suicide gene to enhance their anti-lymphoma/leukemia effects and safety
V. Hoyos et al.
LEUKEMIA (2010)
IL-12 can alleviate Th17-mediated allergic lung inflammation through induction of pulmonary IL-10 expression
D. M. Durrant et al.
MUCOSAL IMMUNOLOGY (2010)
IL-12 initiates tumor rejection via lymphoid tissue-inducer cells bearing the natural cytotoxicity receptor NKp46
Maya Eisenring et al.
NATURE IMMUNOLOGY (2010)
IL-12 delivered intratumorally by multilamellar liposomes reactivates memory T cells in human tumor microenvironments
Michelle R. Simpson-Abelson et al.
CLINICAL IMMUNOLOGY (2009)
Chimeric Receptors Containing CD137 Signal Transduction Domains Mediate Enhanced Survival of T Cells and Increased Antileukemic Efficacy In Vivo
Michael C. Milone et al.
MOLECULAR THERAPY (2009)
Dynamic cross-talk between tumor and immune cells in orchestrating the immunosuppressive network at the tumor microenvironment
Diego O. Croci et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2007)
Polarized type-1 dendritic cells (DC1) producing high levels of IL-12 family members rescue patient T(H)1-type antimelanoma CD4(+) T cell responses in vitro
Amy Wesa et al.
JOURNAL OF IMMUNOTHERAPY (2007)
A self-inactivating retrovector incorporating the IL-2 promoter for activation-induced transgene expression in genetically engineered T-cells
Diana E. Jaalouk et al.
VIROLOGY JOURNAL (2006)
Cancer despite immunosurveillance: immunoselection and immunosubversion
Laurence Zitvogel et al.
NATURE REVIEWS IMMUNOLOGY (2006)
Type, density, and location of immune cells within human colorectal tumors predict clinical outcome
Jerom Galon et al.
SCIENCE (2006)
IL-23 promotes tumour incidence and growth
John L. Langowski et al.
NATURE (2006)
Removal of homeostatic cytokine sinks by lymphodepletion enhances the efficacy of adoptively transferred tumor-specific CD8+ T cells
L Gattinoni et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
New IL-12-family members: IL-23 and IL-27, cytokines with divergent functions
CA Hunter
NATURE REVIEWS IMMUNOLOGY (2005)
Intratumoral recombinant human interleukin-12 administration in head and neck squamous (cell carcinoma patients modifies locoregional lymph node architecture and induces natural killer cell infiltration in the primary tumor
CML van Herpen et al.
CLINICAL CANCER RESEARCH (2005)
The anti-tumor effect of interleukin-12 is enhanced by mild (fever-range) thermal therapy
MT Pritchard et al.
IMMUNOLOGICAL INVESTIGATIONS (2005)
Intratumoral injection of DNA encoding human interleukin 12 into patients with metastatic melanoma: Clinical efficacy
L Heinzerling et al.
HUMAN GENE THERAPY (2005)
Bystander elimination of antigen loss variants in established tumors
MT Spiotto et al.
NATURE MEDICINE (2004)
A strategy for treatment of Epstein-Barr virus-positive Hodgkin's disease by targeting interleukin 12 to the tumor environment using tumor antigen-specific T cells
HJ Wagner et al.
CANCER GENE THERAPY (2004)
T cell activation by antibody-like immunoreceptors: Increase in affinity of the single-chain fragment domain above threshold does not increase T cell activation against antigen-positive target cells but decreases selectivity
M Chmielewski et al.
JOURNAL OF IMMUNOLOGY (2004)
Signal 3 determines tolerance versus full activation of naive CD8 T cells: Dissociating proliferation and development of effector function
JM Curtsinger et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
Interleukin-12 and the regulation of innate resistance and adaptive immunity
G Trinchieri
NATURE REVIEWS IMMUNOLOGY (2003)
Autologous and MHC class I-negative allogeneic tumor cells secreting IL-12 together cure disseminated A20 lymphoma
A Curti et al.
BLOOD (2003)
Expansion of EBV latent membrane protein 2a specific cytotoxic T cells for the adoptive immunotherapy of EBV latency type 2 malignancies: influence of recombinant IL12 and IL15
HJ Wagner et al.
CYTOTHERAPY (2003)
The IL-12 family of heterodimeric cytokines: New players in the regulation of T cell responses
G Trinchieri et al.
IMMUNITY (2003)
IL-12 provides proliferation and survival signals to murine CD4+ T cells through phosphatidylinositol 3-kinase/Akt signaling pathway
JK Yoo et al.
JOURNAL OF IMMUNOLOGY (2002)
IL-12 plays a significant role in the apoptosis of human T cells in the absence of antigenic stimulation
HT Fan et al.
CYTOKINE (2002)
Interleukin 12 gene therapy of cancer by peritumoral injection of transduced autologous fibroblasts: Outcome of a phase I study
WK Kang et al.
HUMAN GENE THERAPY (2001)
Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12
B Oppmann et al.
IMMUNITY (2000)
Interleukin-18 gene transfer increases antitumor effects of suicide gene therapy through efficient induction of antitumor immunity
DW Ju et al.
GENE THERAPY (2000)
分享论文
